East Windsor, N.J. – Aurobindo Pharma Limited has received final approval from U.S. Food and Drug Administration for its Abbreviated New Drug Application Icosapent Ethyl Capsules, 1 gram. Aurobindo Pharma’s Icosapent Ethyl Capsules, are an AB-rated generic equivalent to the reference listed drug (RLD), Vascepa Capsules, manufactured by Amarin Pharmaceuticals Ireland, Limited. Icosapent Ethyl Capsules […] The post Aurobindo Receives FDA Approval for Icosapent Ethyl Capsules, 1 gram appeared first on Aurobindo Pharma USA .